Table 2

Prescribing of recommended daily dose of index NOAC (first NOAC prescription) by eligibility according to the EU label

Daily dose of index NOAC prescribedDosing eligibility
Standard doseReduced doseContraindicatedTotal
(overall eligibility)
Apixabann=9194n=1385n=255n=10 834
 Recommended6850 (74.5)1260 (91.0)NA8110 (74.9)
 Lower than recommended2344 (25.5)0 (0)NA2344 (21.6)
 Higher than recommended0 (0)125 (9.0)NA125 (1.1)
 Prescribed a NOAC when contraindicatedNANA255 (100)255 (2.4)
Dabigatrann=1790n=2357n=234n=4381
 Recommended1409 (78.7)1849 (78.4)NA3258 (74.4)
 Lower than recommended381 (21.3)0 (0)NA381 (8.7)
 Higher than recommended0 (0)508 (21.6)NA508 (11.6)
 Prescribed a NOAC when contraindicatedNANA234 (100)234 (5.3)
Rivaroxabann=12 607n=2638n=7n=15 252
 Recommended11 162 (88.5)1687 (63.9)NA12 849 (84.2)
 Lower than recommended1389 (11.0)0 (0)NA1389 (9.1)
 Higher than recommended56 (0.40)951 (36.1)NA1007 (6.6)
 Prescribed a NOAC when contraindicatedNANA7 (100)7 (0.05)
  • Data are n (column %).

  • EU, European Union; NOAC, non-vitamin K antagonist oral anticoagulant.